Jefferies Group LLC Mirati Therapeutics, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Mirati Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 21,049 shares of MRTX stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,049

Previous 9,816 114.44%

Holding current value

Previous $658,000 123.4%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	BUY	$59.5 - $86.7 $668,363 - $973,901	11,233 Added 114.44%	21,049 $1.47 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $625,285 - $911,130	10,509 Added 99.71%	21,049 $1.47 Million
Q2 2022 Sep 21, 2023	SELL	$39.16 - $88.71 $2.57 Million - $5.81 Million	-65,530 Reduced 86.97%	9,816 $658,000
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $2.6 Million - $5.9 Million	-66,508 Reduced 86.32%	10,540 $669,000
Q1 2022 Sep 21, 2023	BUY	$75.82 - $150.97 $2.12 Million - $4.22 Million	27,965 Added 59.02%	75,346 $6.19 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $2.25 Million - $4.48 Million	29,667 Added 62.61%	77,048 $6.19 Million
Q4 2021 Sep 21, 2023	BUY	$132.01 - $190.29 $5.88 Million - $8.47 Million	44,527 Added 1560.16%	47,381 $6.95 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $5.88 Million - $8.47 Million	44,527 Added 1560.16%	47,381 $6.95 Million
Q2 2021 Sep 21, 2023	SELL	$144.0 - $179.73 $1.05 Million - $1.31 Million	-7,279 Reduced 71.83%	2,854 $461,000
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $1.05 Million - $1.31 Million	-7,279 Reduced 71.83%	2,854 $461,000
Q1 2021 Sep 21, 2023	SELL	$158.92 - $221.61 $13.9 Million - $19.4 Million	-87,447 Reduced 89.62%	10,133 $1.74 Million
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $13.9 Million - $19.4 Million	-87,447 Reduced 89.62%	10,133 $1.74 Million
Q4 2020 Sep 21, 2023	BUY	$162.05 - $240.27 $12.4 Million - $18.4 Million	76,531 Added 363.58%	97,580 $21.4 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $2.22 Million - $3.3 Million	13,725 Added 16.37%	97,580 $21.4 Million
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $346,349 - $511,511	-3,058 Reduced 3.52%	83,855 $13.9 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $46,086 - $77,049	-640 Reduced 0.73%	86,913 $9.92 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $1.6 Million - $2.66 Million	22,932 Added 35.49%	87,553 $6.73 Million
Q4 2019 Feb 13, 2020	SELL	$70.76 - $128.86 $337,666 - $614,919	-4,772 Reduced 6.88%	64,621 $8.33 Million
Q3 2019 Nov 13, 2019	BUY	$77.91 - $109.6 $5.39 Million - $7.58 Million	69,193 Added 34596.5%	69,393 $5.41 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $11,898 - $20,942	200 New	200 $21,000
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $57,600 - $85,374	-1,800 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $84,780 - $112,860	1,800 New	1,800 $85,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Mirati Therapeutics, Inc. Transaction History